LENVATINIB

33515 reported adverse events

Drug classes: Kinase Inhibitor [EPC]

These side effects are most commonly reported by patients taking LENVATINIB:

# Side effect Count
0 DIARRHOEA 4243
1 HYPERTENSION 3829
2 FATIGUE 3425
3 DECREASED APPETITE 3169
4 MALIGNANT NEOPLASM PROGRESSION 2570
5 NAUSEA 2531
6 BLOOD PRESSURE INCREASED 2189
7 VOMITING 2044
8 ASTHENIA 1661
9 DEHYDRATION 1548
See all common reactions for LENVATINIB

LENVATINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PROSTHETIC CARDIAC VALVE OBSTRUCTION 9 0.7500
1 TRACHEAL FISTULA 39 0.2532
2 LIVER CARCINOMA RUPTURED 50 0.1984
3 THYROGLOBULIN DECREASED 9 0.1500
4 PRIMARY ADRENAL INSUFFICIENCY 40 0.1311
5 SILENT THYROIDITIS 18 0.1250
6 THYROGLOBULIN INCREASED 21 0.1235
7 IMMUNE-MEDIATED ADRENAL INSUFFICIENCY 96 0.1205
8 IMMUNE-MEDIATED ENCEPHALITIS 55 0.1040
9 OESOPHAGEAL FISTULA 33 0.1038
See all enriched reactions for LENVATINIB